Alignment Healthcare CMO granted 52,972 RSUs

Kim Hyong reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Kim Hyong reported acquisition or exercise transactions in this Form 4 filing.

Alignment Healthcare, Inc. reported that Chief Medical Officer Hyong Kim received an equity grant of 52,972 shares of Common Stock in the form of restricted stock units at no cash cost. These units vest in roughly equal thirds on each of the first three anniversaries of the grant date, contingent on continued service. Following this grant, Kim holds 386,105 shares directly, underscoring this as a routine, compensation-related award rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 52,972 shares

Grant/Award 1 txn

Insider Kim Hyong

Role Chief Medical Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	52,972	$0.00	$0.00

Holdings After Transaction: Common Stock — 386,105 shares (Direct)

Footnotes (1)

1. F1. Represents 52,972 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Alignment Healthcare (ALHC) report for Hyong Kim?

Alignment Healthcare reported that Chief Medical Officer Hyong Kim received 52,972 restricted stock units of Common Stock as a compensation grant. The award was recorded at a price of $0.00 per share, indicating it is a non-cash equity grant rather than a market purchase.

How do the 52,972 restricted stock units for ALHC’s CMO vest?

The 52,972 restricted stock units vest in approximately one third increments on each of the first three anniversaries of the grant date. Vesting is conditioned on the reporting person’s continued service with Alignment Healthcare through each applicable vesting date, aligning compensation with multi-year retention.

Is the 52,972-share award to ALHC’s Chief Medical Officer an open-market purchase?

No, the 52,972-share transaction is classified as a grant or award acquisition, not an open-market purchase. The Form 4 shows a transaction price of $0.00 per share, confirming it is a compensation-related restricted stock unit grant issued by the company.

What are Hyong Kim’s Alignment Healthcare (ALHC) holdings after this Form 4 transaction?

After receiving the 52,972 restricted stock units, Chief Medical Officer Hyong Kim directly holds 386,105 shares of Alignment Healthcare Common Stock. This total includes the newly granted units, which remain subject to a three-year vesting schedule tied to continued employment with the company.

What does transaction code “A” mean in the ALHC Form 4 for Hyong Kim?

Transaction code “A” on the Form 4 indicates a grant, award, or other acquisition of equity, rather than a market trade. In this case, it reflects a restricted stock unit grant of 52,972 shares of Common Stock to the Chief Medical Officer as part of compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 05:18 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kim Hyong

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CA 92868

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/13/2026		A		52,972(1)	A	$0	386,105	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents 52,972 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Hyong (Ken) Kim	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.